1. Home
  2. BMEA vs MVIS Comparison

BMEA vs MVIS Comparison

Compare BMEA & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • MVIS
  • Stock Information
  • Founded
  • BMEA 2017
  • MVIS 1993
  • Country
  • BMEA United States
  • MVIS United States
  • Employees
  • BMEA N/A
  • MVIS N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • MVIS Industrial Machinery/Components
  • Sector
  • BMEA Health Care
  • MVIS Technology
  • Exchange
  • BMEA Nasdaq
  • MVIS Nasdaq
  • Market Cap
  • BMEA 275.6M
  • MVIS 234.3M
  • IPO Year
  • BMEA 2021
  • MVIS 1996
  • Fundamental
  • Price
  • BMEA $6.38
  • MVIS $0.97
  • Analyst Decision
  • BMEA Buy
  • MVIS Hold
  • Analyst Count
  • BMEA 13
  • MVIS 2
  • Target Price
  • BMEA $37.25
  • MVIS $3.00
  • AVG Volume (30 Days)
  • BMEA 814.9K
  • MVIS 2.1M
  • Earning Date
  • BMEA 10-29-2024
  • MVIS 11-07-2024
  • Dividend Yield
  • BMEA N/A
  • MVIS N/A
  • EPS Growth
  • BMEA N/A
  • MVIS N/A
  • EPS
  • BMEA N/A
  • MVIS N/A
  • Revenue
  • BMEA N/A
  • MVIS $8,147,000.00
  • Revenue This Year
  • BMEA N/A
  • MVIS $24.78
  • Revenue Next Year
  • BMEA N/A
  • MVIS $322.28
  • P/E Ratio
  • BMEA N/A
  • MVIS N/A
  • Revenue Growth
  • BMEA N/A
  • MVIS 277.53
  • 52 Week Low
  • BMEA $3.61
  • MVIS $0.83
  • 52 Week High
  • BMEA $22.74
  • MVIS $2.98
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 24.23
  • MVIS 44.49
  • Support Level
  • BMEA $6.04
  • MVIS $1.03
  • Resistance Level
  • BMEA $9.34
  • MVIS $1.06
  • Average True Range (ATR)
  • BMEA 0.54
  • MVIS 0.06
  • MACD
  • BMEA -0.26
  • MVIS -0.01
  • Stochastic Oscillator
  • BMEA 10.30
  • MVIS 43.04

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

Share on Social Networks: